UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2004, Palliative care consultations, ISBN 9780198528074
eBook
European journal of human genetics : EJHG, ISSN 1018-4813, 2018, Volume 26, Issue 10, pp. 1417 - 1423
Biochemistry & Molecular Biology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Neoplastic Syndromes, Hereditary - drug therapy | Colorectal Neoplasms, Hereditary Nonpolyposis - drug therapy | Colorectal Neoplasms - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - genetics | Humans | Brain Neoplasms - genetics | MutS Homolog 2 Protein - genetics | Brain Neoplasms - complications | Brain Neoplasms - drug therapy | DNA-Binding Proteins - genetics | Germ-Line Mutation - genetics | Neoplasms - drug therapy | Neoplasms - complications | Neoplasms - genetics | Colorectal Neoplasms - drug therapy | MutL Protein Homolog 1 - genetics | Colorectal Neoplasms, Hereditary Nonpolyposis - complications | Neoplastic Syndromes, Hereditary - complications | Aspirin - therapeutic use | Colorectal Neoplasms - complications | Neoplastic Syndromes, Hereditary - genetics | Child | Mismatch Repair Endonuclease PMS2 - genetics | Aspirin | Yeast | MLH1 protein | Brain tumors | Colorectal carcinoma | MSH2 protein | Acetylsalicylic acid | Lymphoma | Disease prevention | MSH6 protein | Developmental stages | Mismatch repair | Children | Health risk assessment | Endometrium | Cancer | Index Medicus | Review
Journal Article
Nature communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 2612 - 11
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Luciferases - metabolism | Membrane Microdomains - metabolism | Humans | Lung Neoplasms - metabolism | Polyethylene Glycols - chemistry | Triple Negative Breast Neoplasms - drug therapy | Brain Neoplasms - metabolism | Luciferases - genetics | Antineoplastic Agents - metabolism | Brain Neoplasms - secondary | Peptides - metabolism | Lung Neoplasms - secondary | Triple Negative Breast Neoplasms - pathology | Female | Receptors, CXCR4 - genetics | Antineoplastic Agents - pharmacology | Liver Neoplasms - secondary | Genes, Reporter | Binding, Competitive | Liver Neoplasms - prevention & control | Lung Neoplasms - genetics | Gene Expression | Liver Neoplasms - genetics | Peptides - chemistry | Brain Neoplasms - genetics | Phosphatidylcholines - chemistry | Antineoplastic Agents - chemistry | Peptides - pharmacology | Receptors, CXCR4 - metabolism | Brain Neoplasms - prevention & control | Xenograft Model Antitumor Assays | Liposomes - chemistry | Animals | Triple Negative Breast Neoplasms - genetics | Lung Neoplasms - prevention & control | Membrane Microdomains - drug effects | Mice, Nude | Triple Negative Breast Neoplasms - metabolism | Liver Neoplasms - metabolism | Cell Line, Tumor | Protein Binding | Liposomes - metabolism | Mice | Phosphatidylethanolamines - chemistry | Cell Movement | Binding | Peptides | Gene regulation | Rafts | Lipid rafts | Breast cancer | Metastasis | Gene expression | Density | CXCR4 protein | Molecular chains | Cell adhesion & migration | Metastases | Signaling | CD18 antigen | Dimers | Liposomes | Cell migration | Cancer | Index Medicus
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 12/2000, Volume 165, Issue 11, pp. 6015 - 6019
Life Sciences & Biomedicine | Immunology | Science & Technology | Mammary Neoplasms, Experimental - immunology | Bone Marrow Neoplasms - immunology | Bone Marrow Neoplasms - genetics | Mammary Neoplasms, Experimental - genetics | STAT6 Transcription Factor | T-Lymphocytes, Cytotoxic - pathology | CD4-Positive T-Lymphocytes - immunology | Cell Differentiation - genetics | Brain Neoplasms - secondary | Brain Neoplasms - immunology | Lung Neoplasms - secondary | Neoplasm Metastasis - immunology | Cell Division - immunology | Neoplasm Metastasis - prevention & control | Mammary Neoplasms, Experimental - pathology | Trans-Activators - genetics | Liver Neoplasms - secondary | Cell Division - genetics | Liver Neoplasms - prevention & control | Lung Neoplasms - genetics | Bone Marrow Neoplasms - prevention & control | Cytotoxicity, Immunologic - genetics | Mammary Neoplasms, Experimental - prevention & control | Liver Neoplasms - genetics | Brain Neoplasms - genetics | Liver Neoplasms - immunology | Lymphatic Metastasis | Bone Marrow Neoplasms - secondary | Disease Progression | Mice, Knockout | Brain Neoplasms - prevention & control | Cell Differentiation - immunology | Neoplasm Metastasis - genetics | Lung Neoplasms - immunology | Animals | Trans-Activators - deficiency | Lung Neoplasms - prevention & control | Neoplasm Metastasis - pathology | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Index Medicus | Abridged Index Medicus
Journal Article
Cancer letters, ISSN 0304-3835, 2017, Volume 403, pp. 159 - 164
Hematology, Oncology and Palliative Medicine | Neoantigens | Prevention | Constitutional mismatch repair deficiency syndrome | CMMRD | Cancer immunotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunotherapy - methods | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | DNA Repair Enzymes - genetics | DNA Mismatch Repair - genetics | Neoplastic Syndromes, Hereditary - mortality | Cancer Vaccines - therapeutic use | Colorectal Neoplasms - therapy | Brain Neoplasms - immunology | Neoplastic Syndromes, Hereditary - genetics | Brain Neoplasms - mortality | Colorectal Neoplasms - mortality | Antibodies - therapeutic use | Antigens, Neoplasm - genetics | Genetic Predisposition to Disease | Antigens, Neoplasm - immunology | Brain Neoplasms - genetics | Cancer Vaccines - adverse effects | Antibodies - adverse effects | DNA Mismatch Repair - immunology | Immunotherapy - adverse effects | Immunotherapy - mortality | Phenotype | Animals | Colorectal Neoplasms - immunology | Brain Neoplasms - therapy | Neoplastic Syndromes, Hereditary - therapy | Mutation | DNA Repair Enzymes - immunology | Care and treatment | Immune response | Endometrial cancer | Brain tumors | Vaccination | Mortality | Colorectal cancer | Development and progression | T cells | Gene mutations | Gastrointestinal diseases | Tumor antigens | Drug therapy | Cancer | Index Medicus
Journal Article
European journal of endocrinology, ISSN 0804-4643, 06/2017, Volume 176, Issue 6, pp. 769 - 777
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | ACTH-Secreting Pituitary Adenoma - drug therapy | ACTH-Secreting Pituitary Adenoma - prevention & control | Follow-Up Studies | Dacarbazine - therapeutic use | Tumor Burden - radiation effects | Humans | Drug Resistance, Neoplasm | Male | Practice Patterns, Physicians | Chemoradiotherapy | Prolactinoma - prevention & control | Prolactinoma - radiotherapy | Neoplasm Recurrence, Local - pathology | Neoplasm Grading | Dacarbazine - analogs & derivatives | Adult | Female | Pituitary Neoplasms - radiotherapy | Retrospective Studies | Carcinoma - pathology | France | Prolactinoma - drug therapy | Pituitary Neoplasms - prevention & control | Prolactinoma - pathology | ACTH-Secreting Pituitary Adenoma - radiotherapy | Carcinoma - drug therapy | Neoplasm Recurrence, Local - prevention & control | Neoplasm Invasiveness | Carcinoma - prevention & control | Pituitary Neoplasms - pathology | Carcinoma - radiotherapy | Antineoplastic Agents, Alkylating - therapeutic use | Pituitary Neoplasms - drug therapy | Tumor Burden - drug effects | Survival Analysis | Neoplasm Recurrence, Local - epidemiology | Temozolomide | ACTH-Secreting Pituitary Adenoma - pathology | Cohort Studies | Carcinoma | Brain tumors | Pituitary | Standardization | Radiation therapy | Survival | Patients | Tumors
Journal Article
Cancer medicine (Malden, MA), ISSN 2045-7634, 01/2020, Volume 9, Issue 1, pp. 361 - 373
mucinous adenocarcinoma | synchronous metastasis | signet ring cell carcinoma | survival analysis | prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | United States - epidemiology | Prognosis | Age Factors | Bone Neoplasms - therapy | Follow-Up Studies | Humans | Middle Aged | Bone Neoplasms - secondary | Bone Neoplasms - epidemiology | Male | Liver Neoplasms - therapy | Liver Neoplasms - epidemiology | Brain Neoplasms - secondary | Neoplasm Grading | Lung Neoplasms - secondary | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Colonic Neoplasms - mortality | Risk Factors | Kaplan-Meier Estimate | Lung Neoplasms - therapy | Chemotherapy, Adjuvant - statistics & numerical data | Adenocarcinoma - secondary | Lung Neoplasms - epidemiology | Adenocarcinoma - therapy | Colonic Neoplasms - pathology | Brain Neoplasms - therapy | Colectomy - statistics & numerical data | Aged | SEER Program - statistics & numerical data | Adenocarcinoma - epidemiology | Neoplasm Staging | Brain Neoplasms - epidemiology | Care and treatment | Cancer patients | Chemotherapy | Colon cancer | Patient outcomes | Analysis | Liver | Metastasis | Epidemiology | CEA (Oncology) | Cancer | Adenocarcinoma | Mortality | Colorectal cancer | Histology | Regression analysis | Survival | Patients | Metastases | Carcinoembryonic antigen | Ethnicity | Marital status | Databases | Medical prognosis | Surgery | Software | Health risk assessment | Tumors | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 06/2017, Volume 123, Issue 11, pp. 1904 - 1911
pembrolizumab | autoimmune | nivolumab | elderly | ipilimumab | pediatrics | pregnancy | transplant | organ dysfunction | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Melanoma - complications | Age Factors | Humans | Immunosuppressive Agents - therapeutic use | Ipilimumab | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Hepatitis C, Chronic - complications | Transplant Recipients | Neoplasms - complications | Brain Neoplasms - secondary | Squamous Cell Carcinoma of Head and Neck | Pregnancy Complications, Neoplastic - drug therapy | Female | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - complications | Graft Rejection - prevention & control | Autoimmune Diseases - complications | Head and Neck Neoplasms - drug therapy | Brain Neoplasms - drug therapy | Lung Neoplasms - complications | Neoplasms - drug therapy | Pregnancy | Carcinoma, Non-Small-Cell Lung - complications | B7-H1 Antigen - antagonists & inhibitors | Carcinoma, Squamous Cell - drug therapy | Hepatitis B, Chronic - complications | Carcinoma, Squamous Cell - complications | Melanoma - drug therapy | Nivolumab | HIV Infections - complications | Head and Neck Neoplasms - complications | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Renal Cell - complications | Immunocompromised Host | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Virus diseases | Care and treatment | Dosage and administration | Research | Cell death | Immunosuppressive agents | Medical research | Brain | Populations | Toxicity | Decision making | Mortality | Disorders | Clinical trials | Cytotoxicity | Lymphocytes T | Metastasis | Patients | Regulatory approval | Metastases | Inhibitors | Immune checkpoint | Aggregates | Lymphocytes | Safety | Autoimmune diseases | Cancer | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Clinical cancer research, ISSN 1078-0432, 05/2014, Volume 20, Issue 10, pp. 2727 - 2739
Life Sciences & Biomedicine | Oncology | Science & Technology | Neurology | Gynecology. Andrology. Obstetrics | Mammary gland diseases | Tumors of the nervous system. Phacomatoses | Pharmacology. Drug treatments | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Antineoplastic agents | Tumors | Immunohistochemistry | Humans | DNA Repair Enzymes - genetics | Antineoplastic Agents, Alkylating - pharmacology | Triple Negative Breast Neoplasms - drug therapy | Brain Neoplasms - metabolism | Breast Neoplasms - metabolism | Dose-Response Relationship, Drug | Brain Neoplasms - secondary | MCF-7 Cells | RNA Interference | Dacarbazine - pharmacology | Tumor Suppressor Proteins - genetics | DNA Repair Enzymes - metabolism | Dacarbazine - analogs & derivatives | Triple Negative Breast Neoplasms - pathology | Female | Tumor Suppressor Proteins - metabolism | DNA Modification Methylases - metabolism | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Breast Neoplasms - drug therapy | Brain Neoplasms - prevention & control | Xenograft Model Antitumor Assays | DNA Modification Methylases - genetics | Animals | Breast Neoplasms - pathology | Mice, Nude | Triple Negative Breast Neoplasms - metabolism | Cell Line, Tumor | Mice | Index Medicus | temozolomide | breast cancer | metastasis | MGMT | Brain metastasis
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 11/2012, Volume 14, Issue 5, pp. v1 - v49
United States - epidemiology | Brain Neoplasms - diagnosis | Humans | Data Collection | Mortality - trends | Central Nervous System Neoplasms - epidemiology | Brain Neoplasms - prevention & control | Confounding Factors (Epidemiology) | Time Factors | Registries - statistics & numerical data | Central Nervous System Neoplasms - prevention & control | Central Nervous System Neoplasms - diagnosis | Brain Neoplasms - epidemiology | Index Medicus
Journal Article